Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Philip Morris International Inc. (PM), Altria Group Inc (MO): This Global Tobacco Business is a Long Term Buy

Shareholders of Philip Morris International Inc. (NYSE:PM) are not happy with its poor returns since the beginning of the year. The company’s share price has risen only 7.10%, much lower than the S&P 500’s gain of 18.70%. Recently, the company also reported sluggish second quarter earnings results. But does that mean it’s a good time to buy Philip Morris International Inc. (NYSE:PM)? Let’s find out.

Sluggish second quarter

Philip Morris International Inc. (NYSE:PM)In the second quarter, Philip Morris International Inc. (NYSE:PM) generated around $20.48 billion in revenue, 2.2% higher than the revenue of $20 billion in the second quarter last year. However, net income fell dramatically by 8.3%, from $2.32 billion to only $2.12 billion, mainly due to higher excise taxes. In addition, cigarette shipment volume decreased by 3.9% to 228.9 billion. In terms of operating income, Philip Morris International Inc. (NYSE:PM) only experienced profit growth in Latin America & Canada, while Asia suffered the worst decline of 17.3%, from $1.36 billion last year to $1.3 billion this year.

As Philip Morris International Inc. (NYSE:PM) did most of its business outside the U.S., the stronger dollar will certainly have a negative impact on the company’s earnings. Excluding the currency effect, the Asia business declined only 9.1%, while the Latin America & Canada actually grew 5.6%. But what investors like about Philip Morris International Inc. (NYSE:PM) is its consistent share buybacks. In the second quarter, the company spent around $1.5 billion to buy back 16.7 million shares.

Is Philip Morris over-leveraged?

Interestingly, the company has used substantial leverage for the purpose of share buybacks. As of June 2013, it had negative equity of $(5.2) billion, $3.59 billion in cash, and nearly $21.56 billion in long-term debt. However, as Philip Morris generates a lot of cash, the leverage ratio (net debt to EBITDA) was quite reasonable, at only 1.52. Philip Morris is trading at $89.60 per share, with a total market cap of $146.4 billion. The market values Philip Morris at 11.5 times its trailing EBITDA.

Philip Morris was spun off from Altria Group Inc (NYSE:MO) in the first quarter of 2008. While Philip Morris focuses its operations in around 180 countries outside of the U.S., Altria Group Inc (NYSE:MO) concentrates on manufacturing and selling tobacco products in the U.S. Altria Group Inc (NYSE:MO)’s business seems to have much slower growth with the stricter regulations in the U.S. Thus, it has a lower valuation, but offers shareholders a higher dividend yield than Philip Morris. At $37 per share, Altria Group Inc (NYSE:MO) is worth $74.15 billion on the market. The market values Altria Group Inc (NYSE:MO) at 10.22 times its trailing EBITDA. The company yields 4.8%, higher than the dividend yield of 3.8% at Philip Morris.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.